John F Crowley Amicus Therapeutics, Inc. (FOLD) insider trading activity

John F Crowley is Executive Chairman of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 573,478 shares of FOLD, which is worth approximately $5.6 Million. The most recent transaction as insider was on Oct 01, 2021, when has been sold 7,500 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $75,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K

0% 3M change

37.14% 12M change

Total Value Held $5.6 Million

John F Crowley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2021	SELL Open market or private sale	$75,000 $10.0 p/Share	7,500 Reduced 0.89%	832,345 Common Stock
Sep 15 2021	SELL Open market or private sale	$243,760 $11.08 p/Share	22,000 Reduced 2.55%	839,845 Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	$96,360 $4.38 p/Share	22,000 Added 2.49%	861,845 Common Stock
Sep 03 2021	SELL Open market or private sale	$62,961 $12.02 p/Share	5,238 Reduced 0.62%	839,845 Common Stock
Sep 03 2021	BUY Exercise of conversion of derivative security	$19,276 $3.68 p/Share	5,238 Added 0.62%	845,083 Common Stock
Sep 01 2021	SELL Open market or private sale	$86,250 $11.5 p/Share	7,500 Reduced 0.89%	839,845 Common Stock
Aug 16 2021	SELL Open market or private sale	$225,940 $10.27 p/Share	22,000 Reduced 2.53%	847,345 Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	$96,360 $4.38 p/Share	22,000 Added 2.47%	869,345 Common Stock
Aug 05 2021	SELL Open market or private sale	$371,110 $10.03 p/Share	37,000 Reduced 4.18%	847,345 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$96,360 $4.38 p/Share	22,000 Added 2.43%	884,345 Common Stock
Jul 12 2021	SELL Open market or private sale	$138,579 $9.31 p/Share	14,885 Reduced 1.7%	862,345 Common Stock
Jun 15 2021	SELL Open market or private sale	$225,720 $10.26 p/Share	22,000 Reduced 2.45%	877,230 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$96,360 $4.38 p/Share	22,000 Added 2.39%	899,230 Common Stock
Jun 07 2021	SELL Open market or private sale	$295,295 $10.01 p/Share	29,500 Reduced 3.25%	877,230 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$119,240 $5.42 p/Share	22,000 Added 2.37%	906,730 Common Stock
May 03 2021	SELL Open market or private sale	$77,100 $10.28 p/Share	7,500 Reduced 0.84%	884,730 Common Stock
Apr 22 2021	SELL Open market or private sale	$76,907 $10.01 p/Share	7,683 Reduced 0.85%	892,230 Common Stock
Apr 15 2021	SELL Open market or private sale	$221,980 $10.09 p/Share	22,000 Reduced 2.39%	899,913 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	$141,900 $6.45 p/Share	22,000 Added 2.33%	921,913 Common Stock
Apr 06 2021	BUY Grant, award, or other acquisition	-	78,389 Added 8.01%	899,913 Common Stock
Apr 01 2021	SELL Open market or private sale	$75,000 $10.0 p/Share	7,500 Reduced 0.9%	821,524 Common Stock
Mar 22 2021	SELL Open market or private sale	$79,048 $10.29 p/Share	7,682 Reduced 0.92%	829,024 Common Stock
Mar 15 2021	SELL Open market or private sale	$236,940 $10.77 p/Share	22,000 Reduced 2.56%	836,706 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$141,900 $6.45 p/Share	22,000 Added 2.5%	858,706 Common Stock
Mar 01 2021	SELL Open market or private sale	$88,875 $11.85 p/Share	7,500 Reduced 0.89%	836,706 Common Stock

Also insider at

NTLA

Intellia Therapeutics, Inc. Healthcare

Director

TRDA

Entrada Therapeutics, Inc. Healthcare

Director

JFC

John F Crowley

Executive Chairman

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account